Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC)
Industry: Biotechnology

OFF LIST - 838 consecutive market days: OFF LIST as of 02/05/2013 Through 11/14/2016

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Current Quote*
Last: $8.230
Change: 0.000
Book: $0.134
Volume: 1,306,040

As Of: 07/17 16:19 ET
*Quotes delayed by 20min.

Graphs for CYCC


3 Month Graph


6 Month Graph


1 Year Graph